anti-SLC6A3 antibody product blog
Tags: Antibody; Polyclonal Antibody; anti-SLC6A3 antibody; SLC6A3; Dopamine transporter type 1;
The SLC6A3 slc6a3 (Catalog #MBS540478) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Dopamine Transporter Antibody Affinity Purified reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s Dopamine Transporter can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB).Dot Blot: 1:10,000
ELISA: 1:10,000
Western Blot: 1:500. Researchers should empirically determine the suitability of the SLC6A3 slc6a3 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The SLC6A3 slc6a3 product has the following accession number(s) (GI #4507041) (NCBI Accession #NP_001035.1) (Uniprot Accession #Q01959). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Dopamine Transporter Antibody Affinity Purified with the following immunoassay(s):
Western Blot (WB)
Affinity Purified Sodium-dependent dopamine transporter Antibody
Amine transporter. Terminates the action of dopamine by its high affinity sodium-dependent reuptake into presynaptic terminals.
Immunogen: Synthetic peptide taken within amino acid region 550-600 on SLC6A3 protein.
Expression: substantia nigra in Brain. Molecular Function: dopamine:sodium symporter activity;monoamine transmembrane transporter activity
Structure: Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family, SLC6A3 subfamily has a Transmembrane helix domain.
Subcellular Location: Cell membrane;Plasma membrane;Multi-pass membrane protein ;Neuronal cell body;axon;Cytoplasm. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing SLC6A3 are readily searchable from our website. Different antibodies against the same target such as SLC6A3 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. SLC6A3 also interacts with the following gene(s): CAMK2A, DRD2, DRD4, NEDD4, PICK1, SLC18A2, SNCA. Attention Deficit Disorder with Hyperactivity, Brain Diseases, Cocaine-Related Disorders, Disease Models, Animal, Movement Disorders, Nervous System Diseases, Parkinson Disease, Parkinsonian Disorders, Poisoning, Schizophrenia are some of the diseases may be linked to Dopamine Transporter Antibody Affinity Purified. Brain, Ganglia, Kidney, Lung, Testis, Thymus, Uncharacterized Tissue tissues are correlated with this protein. The following patways have been known to be associated with this gene.